Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 3/2012

01-03-2012 | Original article

Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions

Authors: Toshitatsu Ogino, Hideya Onishi, Hiroyuki Suzuki, Takashi Morisaki, Masao Tanaka, Mitsuo Katano

Published in: Cancer Immunology, Immunotherapy | Issue 3/2012

Login to get access

Abstract

Dendritic cells (DCs) generated from monocytes under 20% O2 are now used as therapeutic tools for cancer patients. However, the O2 concentration is between 3 and 0.5% in most tissues. We evaluated these complicated functions of DCs under oxygen tensions mimicking in vivo situations. Immature DCs (imDCs) were generated from monocytes using IL-4 and GM-CSF under normoxia (20% O2; N-imDCs) or hypoxia (1% O2; H-imDCs). Mature DCs (mDCs) were induced with LPS. DCs were further exposed to normoxia (N/N-DCs) or hypoxia (N/H-DCs and H/H-DCs) conditions. Using a 2-D culture system, H-DCs were smaller in size than N-DCs, and H/H-DCs exhibited higher allo-T cell stimulation ability than N/N-DCs and N/H-DCs. On the other hand, motility and phagocytic ability of H/H-DCs were significantly lower than those of N/H-DCs and N/N-DCs. In a 3-D culture system, however, maturation of H/H-imDCs and N/H-imDCs was suppressed compared with N/N-imDCs as a result of their decreased motility and phagocytosis. Interestingly, silencing of HIF- by RNA interference decreased CD83 expression without affecting any antigen presentation abilities except for the ability to stimulate the allo-T cell population. Our data could help our understanding of DCs, especially therapeutic DCs, in vivo.
Literature
1.
go back to reference Galy A, Travis M, Cen D, Chen B (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3(4):459–473PubMedCrossRef Galy A, Travis M, Cen D, Chen B (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3(4):459–473PubMedCrossRef
2.
go back to reference Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11(6):753–761PubMedCrossRef Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Differentiation of phagocytic monocytes into lymph node dendritic cells in vivo. Immunity 11(6):753–761PubMedCrossRef
3.
go back to reference Caldwell CC, Kojima H, Lukashev D, Sitkovsky MV et al (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167(11):6140–6149PubMed Caldwell CC, Kojima H, Lukashev D, Sitkovsky MV et al (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167(11):6140–6149PubMed
4.
go back to reference Hockel S, Schlenger K, Vaupel P, Hockel M (2001) Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer. Int J Oncol 19(4):827–832PubMed Hockel S, Schlenger K, Vaupel P, Hockel M (2001) Association between host tissue vascularity and the prognostically relevant tumor vascularity in human cervical cancer. Int J Oncol 19(4):827–832PubMed
5.
go back to reference Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109–1118PubMedCrossRef Sallusto F, Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179(4):1109–1118PubMedCrossRef
6.
go back to reference Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9(1):10–16PubMedCrossRef Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9(1):10–16PubMedCrossRef
7.
go back to reference Soruri A, Zwirner J (2005) Dendritic cells: limited potential in immunotherapy. Int J Biochem Cell Biol 37(2):241–245PubMedCrossRef Soruri A, Zwirner J (2005) Dendritic cells: limited potential in immunotherapy. Int J Biochem Cell Biol 37(2):241–245PubMedCrossRef
8.
go back to reference Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245–252PubMedCrossRef Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392(6673):245–252PubMedCrossRef
9.
go back to reference Thomas R, Chambers M, Boytar R, Andersen J et al (1999) Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy. Melanoma Res 9(5):474–481PubMedCrossRef Thomas R, Chambers M, Boytar R, Andersen J et al (1999) Immature human monocyte-derived dendritic cells migrate rapidly to draining lymph nodes after intradermal injection for melanoma immunotherapy. Melanoma Res 9(5):474–481PubMedCrossRef
10.
go back to reference Banchereau J, Briere F, Caux C, Palucka K et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811PubMedCrossRef Banchereau J, Briere F, Caux C, Palucka K et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767–811PubMedCrossRef
11.
go back to reference Zinkernagel AS, Johnson RS, Nizet V (2007) Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med 85(12):1339–1346PubMedCrossRef Zinkernagel AS, Johnson RS, Nizet V (2007) Hypoxia inducible factor (HIF) function in innate immunity and infection. J Mol Med 85(12):1339–1346PubMedCrossRef
12.
13.
go back to reference Mancino A, Schioppa T, Larghi P, Sica A et al (2008) Divergent effects of hypoxia on dendritic cell functions. Blood 112(9):3723–3734PubMedCrossRef Mancino A, Schioppa T, Larghi P, Sica A et al (2008) Divergent effects of hypoxia on dendritic cell functions. Blood 112(9):3723–3734PubMedCrossRef
14.
go back to reference Bosco MC, Pierobon D, Blengio F, Varesio L et al (2009) Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mDCs: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117(9):2625–2639CrossRef Bosco MC, Pierobon D, Blengio F, Varesio L et al (2009) Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mDCs: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo. Blood 117(9):2625–2639CrossRef
15.
go back to reference Bosco MC, Puppo M, Blengio F, Varesio L et al (2008) Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213(9–10):733–749PubMedCrossRef Bosco MC, Puppo M, Blengio F, Varesio L et al (2008) Monocytes and dendritic cells in a hypoxic environment: spotlights on chemotaxis and migration. Immunobiology 213(9–10):733–749PubMedCrossRef
16.
go back to reference Tasaki A, Yamanaka N, Kubo M, Katano M et al (2004) Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells. J Immunol Methods 287(1–2):79–90PubMedCrossRef Tasaki A, Yamanaka N, Kubo M, Katano M et al (2004) Three-dimensional two-layer collagen matrix gel culture model for evaluating complex biological functions of monocyte-derived dendritic cells. J Immunol Methods 287(1–2):79–90PubMedCrossRef
17.
go back to reference Kim JB (2005) Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 15(5):365–377PubMedCrossRef Kim JB (2005) Three-dimensional tissue culture models in cancer biology. Semin Cancer Biol 15(5):365–377PubMedCrossRef
18.
go back to reference Onishi H, Kuroki H, Katano M, Morisaki T et al (2004) Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop. Cancer Immunol Immunother 53(12):1093–1100PubMedCrossRef Onishi H, Kuroki H, Katano M, Morisaki T et al (2004) Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop. Cancer Immunol Immunother 53(12):1093–1100PubMedCrossRef
19.
go back to reference Onishi H, Morisaki T, Kuroki H, Katano M et al (2005) Evaluation of a dysfunctional and short-lived subset of monocyte-derived dendritic cells from cancer patients. Anticancer Res 25(5):3445–3451PubMed Onishi H, Morisaki T, Kuroki H, Katano M et al (2005) Evaluation of a dysfunctional and short-lived subset of monocyte-derived dendritic cells from cancer patients. Anticancer Res 25(5):3445–3451PubMed
20.
go back to reference Qu X, Yang MX, Kong BH, Lu L et al (2005) Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol Cell Biol 83(6):668–673PubMedCrossRef Qu X, Yang MX, Kong BH, Lu L et al (2005) Hypoxia inhibits the migratory capacity of human monocyte-derived dendritic cells. Immunol Cell Biol 83(6):668–673PubMedCrossRef
21.
go back to reference Ricciardi A, Elia AR, Cappello P, Varesio L et al (2008) Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol Cancer Res 6(2):175–185PubMedCrossRef Ricciardi A, Elia AR, Cappello P, Varesio L et al (2008) Transcriptome of hypoxic immature dendritic cells: modulation of chemokine/receptor expression. Mol Cancer Res 6(2):175–185PubMedCrossRef
22.
go back to reference Zhao W, Darmanin S, Fu Q, Chen J, Kobayashi M et al (2005) Hypoxia suppresses the production of matrix metalloproteinases and the migration of human monocyte-derived dendritic cells. Eur J Immunol 35(12):3468–3477PubMedCrossRef Zhao W, Darmanin S, Fu Q, Chen J, Kobayashi M et al (2005) Hypoxia suppresses the production of matrix metalloproteinases and the migration of human monocyte-derived dendritic cells. Eur J Immunol 35(12):3468–3477PubMedCrossRef
23.
go back to reference Zhao P, Li XG, Yang M, Qu X et al (2008) Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol Immunol 45(8):2187–2195PubMedCrossRef Zhao P, Li XG, Yang M, Qu X et al (2008) Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol Immunol 45(8):2187–2195PubMedCrossRef
24.
go back to reference Du R, Lu KV, Petritsch C, Bergers G et al (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3):206–220PubMedCrossRef Du R, Lu KV, Petritsch C, Bergers G et al (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13(3):206–220PubMedCrossRef
25.
go back to reference Faveeuw C, Preece G, Ager A (2001) Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 98(3):688–695PubMedCrossRef Faveeuw C, Preece G, Ager A (2001) Transendothelial migration of lymphocytes across high endothelial venules into lymph nodes is affected by metalloproteinases. Blood 98(3):688–695PubMedCrossRef
26.
go back to reference Elia AR, Cappello P, Puppo M, Giovarelli M et al (2008) Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J Leukoc Biol 84(6):1472–1482PubMedCrossRef Elia AR, Cappello P, Puppo M, Giovarelli M et al (2008) Human dendritic cells differentiated in hypoxia down-modulate antigen uptake and change their chemokine expression profile. J Leukoc Biol 84(6):1472–1482PubMedCrossRef
27.
go back to reference Nam EH, Park SR, Kim PH (2010) TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions. Exp Mol Med 42(9):606–613PubMedCrossRef Nam EH, Park SR, Kim PH (2010) TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions. Exp Mol Med 42(9):606–613PubMedCrossRef
28.
go back to reference Riboldi E, Musso T, Moroni E, Sozzani S et al (2005) Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J Immunol 175(5):2788–2792PubMed Riboldi E, Musso T, Moroni E, Sozzani S et al (2005) Cutting edge: proangiogenic properties of alternatively activated dendritic cells. J Immunol 175(5):2788–2792PubMed
29.
go back to reference Gabrilovich DI, Chen HL, Girgis KR, Carbone DP et al (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10):1096–1103PubMedCrossRef Gabrilovich DI, Chen HL, Girgis KR, Carbone DP et al (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10):1096–1103PubMedCrossRef
30.
go back to reference Gabrilovich D, Ishida T, Oyama T, Carbone DP et al (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92(11):4150–4166PubMed Gabrilovich D, Ishida T, Oyama T, Carbone DP et al (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92(11):4150–4166PubMed
31.
go back to reference Alfaro C, Suarez N, Gonzalez A, Perez-Gracia JL et al (2009) Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer 100(7):1111–1119PubMedCrossRef Alfaro C, Suarez N, Gonzalez A, Perez-Gracia JL et al (2009) Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes. Br J Cancer 100(7):1111–1119PubMedCrossRef
32.
go back to reference Hirano N, Butler MO, Xia Z, Nadler LM et al (2006) Engagement of CD83 ligand induces prolonged expansion of CD8 + T cells and preferential enrichment for antigen specificity. Blood 107(4):1528–1536PubMedCrossRef Hirano N, Butler MO, Xia Z, Nadler LM et al (2006) Engagement of CD83 ligand induces prolonged expansion of CD8 + T cells and preferential enrichment for antigen specificity. Blood 107(4):1528–1536PubMedCrossRef
33.
go back to reference Aerts-Toegaert C, Heirman C, Tuyaerts S, Breckpot K et al (2007) CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37(3):686–695PubMedCrossRef Aerts-Toegaert C, Heirman C, Tuyaerts S, Breckpot K et al (2007) CD83 expression on dendritic cells and T cells: correlation with effective immune responses. Eur J Immunol 37(3):686–695PubMedCrossRef
34.
go back to reference Zhou LJ, Tedder TF (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154(8):3821–3835PubMed Zhou LJ, Tedder TF (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154(8):3821–3835PubMed
35.
go back to reference Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A (2007) CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J Immunol 178(9):5454–5464PubMed Prechtel AT, Turza NM, Theodoridis AA, Steinkasserer A (2007) CD83 knockdown in monocyte-derived dendritic cells by small interfering RNA leads to a diminished T cell stimulation. J Immunol 178(9):5454–5464PubMed
36.
go back to reference Kuga H, Morisaki T, Nakamura K, Katano M et al (2003) Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Oncogene 22(49):7838–7847PubMedCrossRef Kuga H, Morisaki T, Nakamura K, Katano M et al (2003) Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model. Oncogene 22(49):7838–7847PubMedCrossRef
Metadata
Title
Inclusive estimation of complex antigen presentation functions of monocyte-derived dendritic cells differentiated under normoxia and hypoxia conditions
Authors
Toshitatsu Ogino
Hideya Onishi
Hiroyuki Suzuki
Takashi Morisaki
Masao Tanaka
Mitsuo Katano
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Cancer Immunology, Immunotherapy / Issue 3/2012
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-011-1112-5

Other articles of this Issue 3/2012

Cancer Immunology, Immunotherapy 3/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine